Phreesia Announces Board Restructuring, New Independent Chair, and Executive Compensation Details
summarizeSummary
Phreesia is implementing significant board changes, including a new independent Chair and a new director, while reporting strong fiscal 2026 financial results and detailing executive compensation, which saw high bonuses but also unvested performance-based equity from prior years.
check_boxKey Events
-
Board Restructuring and New Leadership
The board will be reduced from nine to seven directors, with two current directors retiring. Ramin Sayar will become the independent Board Chair, and Jon Kessler, an experienced public company CEO, has been nominated as a new Class I director.
-
Executive Bonus Payouts
Executive officers received 140.3% of their target cash incentive bonuses for fiscal year 2026, with most electing to receive 100% of their bonus in fully-vested RSUs at a 15% premium.
-
Underperforming Equity Awards
Performance Stock Units (PSUs) granted in fiscal 2023 did not vest because the company's Total Shareholder Return (TSR) was below the 20th percentile relative to the Russell 3000 index over the three-year performance period.
-
Fiscal 2026 Financial Highlights
The company reported a return to GAAP profitability with net income of $2.3 million and strong Adjusted EBITDA of $101.5 million for fiscal year 2026.
auto_awesomeAnalysis
This definitive proxy statement outlines significant corporate governance changes, including a reduction in board size, the retirement of two directors, and the appointment of a new independent Board Chair. It also introduces a new director with extensive public company CEO experience. The filing provides detailed executive compensation information, highlighting a strong bonus payout for fiscal 2026, but also reveals that performance-based equity awards from 2023 failed to vest due to underperformance, demonstrating a direct link between executive pay and shareholder returns. The reported return to GAAP profitability and strong Adjusted EBITDA for fiscal 2026 are positive financial indicators.
At the time of this filing, PHR was trading at $8.77 on NYSE in the Trade & Services sector, with a market capitalization of approximately $532.9M. The 52-week trading range was $7.77 to $32.76. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.